Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates ...
Nearly 1 in 3 patients with systemic lupus erythematosus (SLE) are taking a supplement-medication combination with potential ...
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced t ...
"I want to take supplements that are good for my hair," or "I'm worried about hair loss, so I want to rethink my nutrition." ...
U.S. FDA Approves Expanded Indication for BMS’s CAMZYOS for the Treatment of Symptomatic oHCM in Adults and Pediatric Patients ...
By Dennis Thompson HealthDay ReporterMONDAY, Sept. 28, 2026 (HealthDay News) — More than 1 in 5 seniors are at risk for a ...
More than one in five older Americans are taking combinations of medications that could lead to major drug interactions, despite a modest decline in such risks over recent years, according to a new ...
Older Americans are increasingly taking multiple prescription medications and dietary supplements. Although the prevalence of potentially major drug-drug interactions has declined slightly, more than ...
A cross-sectional study analyzed the changing use of medications and dietary supplements in the U.S. between 2015-2016 and 2021-2023. Polypharmacy involving prescription medications and dietary ...
The European Medicines Agency (EMA) has published a guideline on evaluating drug interactions in the gastrointestinal tract that addresses situations in which extrinsic factors in the gastrointestinal ...
An MCP server for longevity & metabolic medicine — a medication catalog, evidence-based dosing protocols, contraindication screening, drug-interaction checks, required baseline labs, ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results